Sentiment Trading

Ovid Therapeutics Inc. is struggling financially and facing skepticism from investors, casting doubt on its ability to deliver on its mission to develop treatments for rare neurological disorders.

Ovid Therapeutics Inc’s stock price has experienced significant volatility, raising concerns about the company’s market valuation and future prospects despite its mission to develop treatments for rare neurological disorders.